--:-- [Theme music fades out]
--:-- Jessica Mendoza: Welcome to The Journal, our show about money, business, and power. I'm Jessica Mendoza. It's Friday, June 6th. This is Medicare, Inc. Part 1. How private insurers pocketed billions from Medicare.
--:-- [Soft music continues in the background]
--:-- Jessica Mendoza: Medicare is America's government-run health care plan. It provides care for anyone 65 and over and some people with disabilities. But what a lot of people may not realize is that a majority of those on Medicare get it through a program called Medicare Advantage.
--:-- Chris Weaver: Yeah, there's more than 60 million people in Medicare, and more than half of those are in Medicare Advantage at this point.
--:-- Jessica Mendoza: And the thing about Medicare Advantage is that the plans are paid for by the government, but managed by private insurance companies.
--:-- Chris Weaver: Medicare Advantage is sort of dominated by these huge insurance companies like UnitedHealth Group, Humana, Aetna, and Elevance.
--:-- Jessica Mendoza: And that's really why we called the series at some level Medicare, Inc. Because people think, oh, this is a government program. But it's also a huge, huge, huge business for some of the biggest companies in America.
--:-- Jessica Mendoza: I'm Chris Weaver. I'm Anna Wildey-Matthews. I'm an investigative reporter at The Wall Street Journal. And I cover health insurance for The Wall Street Journal.
--:-- Anna Wildey-Matthews: My colleagues Anna and Chris have been investigating the Medicare Advantage program for over a year.
--:-- Chris Weaver: So when you and the team looked into the program, what did you find? What we found was that Medicare Advantage insurers were basically gaming the system to get paid billions of dollars more.
--:-- Anna Wildey-Matthews: And at the same time creating barriers to accessing care.
--:-- Jessica Mendoza: Over the next two episodes, we'll lay out some of what the journal's investigative reporting team found. Today is about how insurers use questionable practices to profit off of the Medicare system.
--:-- Chris Weaver: In total, what we determined was that Medicare Advantage insurers over a three-year period had got paid $50 billion for diagnoses that they alone added to patients' records.
--:-- Jessica Mendoza: And what astounded me was basically the magnitude and just the total amount of dollars that they were getting from sort of chasing that incentive to make people be sicker on paper.
--:-- Jessica Mendoza: Welcome to The Journal, our show about money, business, and power. I'm Jessica Mendoza.
--:-- Anna Wildey-Matthews: So, Ana, Chris, why did you guys want to look into Medicare Advantage in the first place?
--:-- Chris Weaver: Medicare Advantage cost the federal government more than $460 billion last year. That's a lot of money.
--:-- Anna Wildey-Matthews: Yeah, that's right. So we decided to dip into this area, which is just a huge portion of the federal budget, so we could see how these giant insurers were operating, what kind of care they were providing, and how much they were getting paid.
--:-- Jessica Mendoza: In 2023, the investigations team got their hands on Medicare data that goes back about a decade. The information included things like service charges and other records.
--:-- Chris Weaver: Once you sort of have the data in your hands, that's just really only the beginning of the process. Nothing is simple in this program.
--:-- Anna Wildey-Matthews: Nothing is simple about how the insurers are paid. Nothing is really simple about what they do.
--:-- Jessica Mendoza: So we paired that with extensive interviews of doctors, medical providers, patients, and other people who interact with the system.
--:-- Chris Weaver: As they went through the data, something stood out to Chris. There were diagnoses on patients' records that were put there by insurers.
--:-- Jessica Mendoza: This is important because of how Medicare Advantage works. For certain kinds of diagnoses, many of which are expensive to treat, the private insurer gets an extra payment from the government.
--:-- Chris Weaver: That payment is meant to cover the cost of treatment. The federal government pays insurers essentially monthly lump sums to cover all of their care.
--:-- Anna Wildey-Matthews: And those lump sums go up when people are sicker.
--:-- Jessica Mendoza: So an example would be somebody who's obese might generate a 30% higher payment for the insurer than the same person who's not.
--:-- Chris Weaver: Or somebody who has diabetes might generate for the insurer a 10% higher payment than somebody who doesn't.
--:-- Jessica Mendoza: And in Medicare Advantage, the incentives are basically to make patients look sicker on paper because insurers get paid more when they do that.
--:-- Jessica Mendoza: And what do the health insurance companies have to say about your reporting?
--:-- Anna Wildey-Matthews: Insurers have defended their practices. They've argued that some of their practices lead to diagnosing patients with serious conditions sooner so they can get the treatment that they need.
--:-- Chris Weaver: They argue that their practices lead to better outcomes for patients and end up costing beneficiaries less than traditional Medicare.
--:-- Jessica Mendoza: Last year, the team published a series of stories based on the data and their reporting.
--:-- Anna Wildey-Matthews: One of those stories caught the eye of a nurse practitioner and what she read really resonated with her.
--:-- Kristen Bell: All of the things that I been feeling and dealing with over the past seven years were sitting there in front of me on a piece of paper which is why I wrote to Chris and said you are spot on.
--:-- Jessica Mendoza: I'm Kristen Bell, and I'm from Maine. I'm a nurse practitioner, and I worked for UnitedHealthcare for seven and a half years.
--:-- Kristen Bell: You have the same name as the actress. Does that ever come up?
--:-- Anna Wildey-Matthews: Yeah. So my patients would always be like, you're not the Kristen Bell. And I'd be like, yeah, sorry.
--:-- Jessica Mendoza: Kristen started working for UnitedHealth in 2017. She'd visit patients at their homes as part of a program called House Calls.
--:-- Kristen Bell: It's available to people who are signed up for the company's Medicare Advantage plans.
--:-- Jessica Mendoza: The idea behind the program, according to UnitedHealth, is to help improve care.
--:-- Kristen Bell: For instance, by catching diseases early, especially if it's something a doctor might have missed.
--:-- Jessica Mendoza: The nurse practitioner visits usually took about an hour, and Kristen says she saw around four patients a day.
--:-- Kristen Bell: She says the work felt meaningful. I liked the customer service aspect of it.
--:-- Jessica Mendoza: You know, the reason that it was good is because the people didn't have primary care provider or intermittent primary care, especially in the rural areas.
--:-- Kristen Bell: The information that we were able to glean was really helpful.
--:-- Jessica Mendoza: And I can't tell you how many times I would go over medications with people and they'd be missing something or they'd be taking it wrong.
--:-- Jessica Mendoza: UnitedHealth told us that it sends home visit findings to primary care doctors and that the visits are not intended to replace appointments with them.
--:-- Kristen Bell: As part of her visits, Kristen did a lot of testing on her patients.
--:-- Jessica Mendoza: What were you trying to assess with each patient?
--:-- Kristen Bell: I was trying to assess where they needed help.
--:-- Jessica Mendoza: So, for example, we were doing urine test strips, and that gave me a lot of information about how somebody was doing.
--:-- Kristen Bell: Oh, you're dehydrated. Oh, you have kidney disease. Oh, you have glucose in your urine.
--:-- Jessica Mendoza: I'm going to call your doctor. You know, that kind of stuff.
--:-- Jessica Mendoza: Were you being directed to do anything specific, these visits by your employer or your manager?
--:-- Kristen Bell: Well, it didn't seem so at first.
--:-- Jessica Mendoza: After she'd been with house calls for a little while, Kristen noticed some things that made her pause.
--:-- Kristen Bell: Like when she entered a patient's information into her laptop or tablet, she says the UnitedHealth software would automatically start suggesting diagnoses based on what she put in.
--:-- Jessica Mendoza: Documents show that these suggestions would appear in a so-called diagnosis cart on the side of the screen, and the suggestions would show up even if the patient didn't feel any symptoms.
--:-- Kristen Bell: UnitedHealth told us that the final diagnosis was left up to the nurse practitioner and that the company is confident that its clinicians act in good faith.
--:-- Jessica Mendoza: Kristen also started getting the message from a manager that she should do more testing on her patients.
--:-- Kristen Bell: My first year, I refused to do some of the tests that they asked us to do because I was like, this patient is asymptomatic.
--:-- Jessica Mendoza: I'm going to call your doctor. You know, that kind of stuff.
--:-- Kristen Bell: I'm not doing this test on this patient. It's just a waste of their time. It's a waste of my time.
--:-- Jessica Mendoza: There's nothing to be gathered from this.
--:-- Kristen Bell: And then when I had my annual review, my manager was like, you know, you did a great job and your patients love you and everything.
--:-- Jessica Mendoza: But what you really need to work on is, you know, the testing that we're trying to deliver to the patients.
--:-- Kristen Bell: And I said, look, you know, if somebody is asymptomatic, you know, you don't test somebody for everything.
--:-- Jessica Mendoza: If they come into the hospital, you test them for what they're having difficulties with.
--:-- Kristen Bell: She said to me, Kristen, we're not billing for any of this. Just do the testing. Just do it.
--:-- Jessica Mendoza: And I was like, OK.
--:-- Jessica Mendoza: After working at the House Calls program for about a year, Kristen told us that she eventually began doing the tests she was asked to do.
--:-- Kristen Bell: And after that, she got a raise.
--:-- Jessica Mendoza: So that's when I was like, ah, that's kind of sketchy. You know, there's something going on here.
--:-- Jessica Mendoza: United Health told us that their nurse practitioners are not, quote, incentivized based on the number of conditions they diagnose.
--:-- Chris Weaver: Chris looked at a three-year period where Medicare Advantage insurers sent out nurse practitioners like Kristen to run tests and add diagnoses to patient records, including diagnoses of the kinds of conditions that trigger those extra payments.
--:-- Jessica Mendoza: The extra payments added up to about $15 billion during that time.
--:-- Chris Weaver: And some of those diagnoses weren't even real.
--:-- Jessica Mendoza: That's next.
--:-- Jessica Mendoza: Chris and Ana found that diagnoses weren't just showing up on Medicare Advantage patient records after home visits.
--:-- Anna Wildey-Matthews: They were also on records after patients went to see doctors or hospitals.
--:-- Jessica Mendoza: The team found that over a three-year period, all of these additional diagnoses added up to $50 billion in federal payments to the insurers.
--:-- Jessica Mendoza: These are conditions that no doctor or hospital treated and that insurers basically went behind the scenes to add or dispatch nurses to patients houses to sort of work them over do a bunch of tests that kind of thing
--:-- Jessica Mendoza: But for which they were getting no care
--:-- Jessica Mendoza: And it was astounding
--:-- Jessica Mendoza: And UnitedHealth more than any other insurer engaged in those practices
--:-- Jessica Mendoza: The biggest Medicare Advantage provider, UnitedHealth, told us that the added payments help cover medical care and lower premiums and provide other benefits for members.
--:-- Jessica Mendoza: It also says that chart reviews reflect diagnoses made by patients' doctors.
--:-- Jessica Mendoza: According to the journal's reporting, some of the diagnoses that insures added to patient records were demonstrably false.
--:-- Anna Wildey-Matthews: One condition that they looked into was diabetic cataracts.
--:-- Jessica Mendoza: Cataracts, which is when eyes cloud over, are common in the elderly.
--:-- Jessica Mendoza: So is diabetes.
--:-- Jessica Mendoza: But there's another, rarer condition called diabetic cataracts, which is when high blood sugar levels cause that cloudy vision.
--:-- Jessica Mendoza: and a diagnosis of diabetic cataracts was tied to thousands of dollars in extra payments, whereas regular cataracts weren't.
--:-- Jessica Mendoza: According to the data seen by the journal team, UnitedHealth Medicare Advantage members were about 15 times as likely to have a diagnosis of diabetic cataracts compared to the average patient in traditional Medicare.
--:-- Jessica Mendoza: It was this unusual condition that Kristen, the nurse practitioner with House Calls, says she was encouraged to put down on patient charts.
--:-- Kristen Bell: So, for example, if somebody has diabetes, you know, and I look in their eyes and I see cataracts, I would put cataracts as a diagnosis, but then they would throw it back at me and say, no, no, no, no, it's diabetes with diabetic cataracts, even though I didn't know if the diabetes caused the cataracts.
--:-- Jessica Mendoza: Well, we know that the person has diabetes and, you know, just, you know, just kind of do it.
--:-- Jessica Mendoza: Eye doctors interviewed by the Journal team said it was unlikely that such a large share of UnitedHealth patients could have this relatively rare disease.
--:-- Jessica Mendoza: Chris also saw patterns in the data that implied some of the patients who were getting diagnosed with diabetic cataracts didn't have the condition at all.
--:-- Jessica Mendoza: For instance, thousands of patients who received the diagnosis had no record of ever being treated for diabetes, while other patients had already had their cataracts treated.
--:-- Jessica Mendoza: They had already had the lenses of both eyes surgically removed and replaced during routine cataract surgeries, and it's literally impossible to get cataracts again after you've had cataract surgery in both eyes.
--:-- Jessica Mendoza: UnitedHealth told us they asked their clinicians to use their medical judgment and diagnosing.
--:-- Jessica Mendoza: The company also said it complies with guidance from the Department of Health and Human Services.
--:-- Jessica Mendoza: Now remember, the way Medicare Advantage works is that insurers get paid more by the government for certain diagnoses.
--:-- Jessica Mendoza: Because diabetic cataracts are a costly condition, they come with a big payment, one that added up over time.
--:-- Jessica Mendoza: During the three-year period that Chris looked at, the government paid insurers more than $700 million just for recording diabetic cataracts, even if no doctor provided any treatment.
--:-- Jessica Mendoza: And Medicare Advantage insurers diagnosed all sorts of diseases that were never treated.
--:-- Jessica Mendoza: Like peripheral artery disease.
--:-- Jessica Mendoza: It's a serious condition where blood vessels get narrower, and in some cases, it can lead to amputations.
--:-- Jessica Mendoza: A house calls training manual reviewed by the investigations team advised nurse practitioners like Kristen to diagnose peripheral artery disease based on results from a device called the Quantiflow.
--:-- Jessica Mendoza: The quantiflow is kind of like a pulse oximeter that gets put on each foot and each hand, and then they compare the hand to the feet.
--:-- Jessica Mendoza: And what we're looking for is, is there decreased blood flow to the feet?
--:-- Jessica Mendoza: If the quantiflow showed decreased blood flow, Kristen was supposed to conclude that the patient had peripheral artery disease.
--:-- Jessica Mendoza: But she says she was uncomfortable making such a definitive diagnosis just based on the device, especially since elderly people often have decreased blood flow.
--:-- Jessica Mendoza: It was a one-data point diagnosis, right?
--:-- Jessica Mendoza: Which isn't necessarily a good way to diagnose anything.
--:-- Jessica Mendoza: But at that split second, if the quantiflow said that the person had peripheral artery disease, at that split second, they had peripheral artery disease.
--:-- Jessica Mendoza: But the quantiflow had problems.
--:-- Jessica Mendoza: The quantaflow it wasn't very specific basically at a high a relatively high rate of false positives and you know under certain circumstances nurses who used it would say you know cold in the room or something that might produce an inaccurate result and you know one nurse said she used it on herself because she was so concerned about the readings that it was producing and found that she herself apparently had peripheral artery disease, even though, like, actually she has no signs of it.
--:-- Jessica Mendoza: The maker of Quantiflow, Semler Scientific, said the device assesses risk for the disease.
--:-- Jessica Mendoza: UnitedHealth told us that it tests for the disease during home visits to diagnose it early, and that it expected clinicians to use their judgment.
--:-- Jessica Mendoza: According to the journal's reporting, those peripheral artery disease diagnoses led to nearly $1.4 billion in additional payments to UnitedHealth between 2019 and 2021.
--:-- Jessica Mendoza: Semler Scientific was also under investigation by the Justice Department for potential fraud
--:-- Jessica Mendoza: The company announced in May it had reached a tentative agreement to settle the case for nearly million
--:-- Jessica Mendoza: The company did not respond to requests for comment about the investigation
--:-- Jessica Mendoza: Those questionable diagnoses weren't just for rare diseases like diabetic cataracts or peripheral artery disease.
--:-- Jessica Mendoza: They were also for HIV, the virus that causes AIDS.
--:-- Jessica Mendoza: During a four-year period, thousands of Medicare Advantage recipients had diagnoses of HIV added to their records by their insurance companies.
--:-- Jessica Mendoza: For each of these diagnoses, insurers received a payment of about $3,000 a year.
--:-- Jessica Mendoza: But when Chris looked into patients' follow-up care, many of them weren't getting it.
--:-- Jessica Mendoza: There were no physician claims.
--:-- Jessica Mendoza: There were no drugs prescribed to them.
--:-- Jessica Mendoza: And 100% of those people, ideally, if they actually have HIV, would be getting antiretroviral therapy.
--:-- Jessica Mendoza: And in reality, fewer than one in five were.
--:-- Jessica Mendoza: Right, because the point of being diagnosed is so that you can get treatment.
--:-- Jessica Mendoza: Yeah, right.
--:-- Jessica Mendoza: That's right.
--:-- Jessica Mendoza: We interviewed a bunch of experts about this particular finding, you know, AIDS specialist, and they almost universally concluded that those people didn't really have HIV.
--:-- Jessica Mendoza: What they surmised is basically that they were getting tested for HIV, screened for HIV, and that, you know, however the insurers were reviewing charts to add diagnoses on the back end, they were picking up those screening exams and just like inferring a diagnosis out of it.
--:-- Jessica Mendoza: Chris says that because of the way this diagnosis is added to a patient's records, some people may not even know about it.
--:-- Jessica Mendoza: Among the UnitedHealth patients, according to Medicare data, hardly anyone given an HIV diagnosis in that period had started antiretroviral treatment in the following years.
--:-- Jessica Mendoza: The company said it disputes the journal's analysis, adding that its internal data from a year later, 2022, showed a treatment rate of more than triple what the journal found.
--:-- Jessica Mendoza: Last year, Medicare Advantage insurance companies were paid more than $460 billion.
--:-- Jessica Mendoza: Who ends up paying for that?
--:-- Jessica Mendoza: Where is that money coming from?
--:-- Jessica Mendoza: That's us, right?
--:-- Jessica Mendoza: It's a taxpayer-funded program.
--:-- Jessica Mendoza: You pay Medicare taxes with each of your paychecks, and that's where it goes.
--:-- Jessica Mendoza: And some of this money was going toward diseases that no doctor ever treated.
--:-- Jessica Mendoza: Right?
--:-- Jessica Mendoza: Does that mean the system isn't really working?
--:-- Jessica Mendoza: I mean, the problem here is that insurers are layering diagnoses on patients, generating billions and billions and billions of dollars more in taxpayer-funded reimbursement.
--:-- Jessica Mendoza: And in many cases, the patients don't have them, aren't getting treated for them.
--:-- Jessica Mendoza: And that's waste.
--:-- Jessica Mendoza: That's waste for taxpayers.
--:-- Jessica Mendoza: For private insurers, Medicare Advantage has driven a huge amount of growth in that industry and vast changes in the way health care is provided and paid for.
--:-- Jessica Mendoza: It's added to the kind of the runaway costs of American health care.
--:-- Jessica Mendoza: So it sounds like there are some holes in the system.
--:-- Jessica Mendoza: Yeah, I mean, there's a lot of ways to make money in Medicare.
--:-- Jessica Mendoza: And, you know, that's fueled a lot of growth in the industry.
--:-- Jessica Mendoza: And, you know, our stories are just some of the strategies that, you know, these companies have embraced.
--:-- Jessica Mendoza: Billing for costly or unnecessary diagnoses, that's one strategy.
--:-- Jessica Mendoza: Another strategy is withholding care from patients who actually need it.
--:-- Jessica Mendoza: The Journal reported on this too.
--:-- Jessica Mendoza: We found that people in their last year of life left Medicare Advantage and went back to traditional Medicare at double the rates of other enrollees.
--:-- Jessica Mendoza: That's my colleague Anna again.
--:-- Anna Wildey-Matthews: Why would people in that last year of life leave Medicare Advantage at a higher rate than everybody else?
--:-- Jessica Mendoza: It raises the question of whether these people who are very sick and have very intense and expensive health needs were running into barriers in accessing the care that they wanted or the care that they felt they needed.
--:-- Jessica Mendoza: We'll hear more from Ana tomorrow on the second part of Medicare, Inc.
--:-- Jessica Mendoza: That's all for today, Friday, June 6th.
--:-- Jessica Mendoza: This episode was produced by Jivika Verma and edited by Laura Morris.
--:-- Jessica Mendoza: Additional reporting by Mark Maramont, Tom McGinty, and Andrew Malica.
--:-- Jessica Mendoza: The Journal is a co-production of Spotify and The Wall Street Journal.
--:-- Jessica Mendoza: The show is made by Our engineers are Griffin Tanner, Nathan Singapok, and Peter Leonard.
--:-- Jessica Mendoza: Our theme music is by So Wiley.
--:-- Jessica Mendoza: Additional music this week from Katherine Anderson, Peter Leonard, Billy Libby, Emma Munger, So Wiley, and Blue Dot Sessions.
--:-- Jessica Mendoza: Fact-checking by Mary Mathis.
--:-- Jessica Mendoza: Thanks for listening. See you tomorrow.
--:-- [Theme music fades in]
--:-- Jessica Mendoza: The Journal is a co-production of Spotify and The Wall Street Journal.
--:-- [Theme music continues to play as the episode ends]
